- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Tags
drug development Partnering Investment economic development Health Care Industry Analysis FDA IPO patent 2012 BIO International Convention BIOTECH economy biotechnology BIO International Convention PUBLIC BIOTECH - Stock performance Biotechnology Industry PUBLIC BIOTECH - Stats biotech industry Events One-on-One'sAuthors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Corporate
- Biofuels & Climate Change
- Biotech Blog
- Business & Investments
- Business of Biotech
- Capital Business
- Corporate
- Environmental & Industrial
- Events
- Farmer Gene
- FierceBiotech
- Food & Agriculture
- Genome Alberta
- Health
- Inside BIO Industry Analysis
- IP Watchdog
- Life Science Leader
- One-on-One Partnering
- Patent Baristas
- Patent Docs
- Patently BIOtech
- PharmTech Talk
- Public Policy
- Snapshot
- Trade Secrets Blog
Latest From Biotech Now
ALS Awareness Month: 10 Things You Should Know About ALS
By Steve Perrin, Ph.D., Chief Executive Officer and CSO, ALS Therapy Development Institute May is a month full of many exciting and celebratory days: college graduations, Mother’s day and Memorial Day. It is a month typified by excitement, renewal, anticipation and remembrance. It is also the month in the United States where we recognize all those living with ALS, commonly known as Lou Gehrig’s disease. If you don’t know someone already living with this currently Read More >
The Scheduling Process
Scheduling for companies will kick into full gear the week of May 28th for the BIO Business Forum and participating exhibiting companies. As mentioned in a previous post, we wanted to discuss scheduling in a bit more detail, so that you understand what scheduling means, and how it impacts the way you use the Partnering System. First and foremost, meetings are only scheduled for those in Accepted/Agreed-To status. Your action item? Go in to your Read More >
People With Rare Diseases Face a Host of Unique Challenges
By Dennis Jackman, Senior Vice President, Public Affairs, CSL Behring People with rare and serious medical disorders encounter a host of unique challenges–from obtaining a correct diagnosis, to identifying an appropriate course of treatment and gaining affordable access to the care they need. They and their families, caretakers and health care providers face a constant struggle to identify and access available resources, away from the attention of traditional media that focuses on more common disorders Read More >
Monday Items for #BIO2012 Business Forum
Happy Monday Everyone! We thought we would do a quick post on some important items concerning the BIO Business Forum and One-on-One Partnering. The Profile Publication Deadline is May 22nd. Why is this important? For one, if you have not published your profile, companies just have a harder time finding you. Make it easy for them. Fill out your keywords; provide as much detail in the assets/products/services categories as possible; Publish and Save! Second, publishing Read More >
Mayo v. Prometheus: Thought Leaders Express Concern and Evaluate the Impact
The Mayo v. Prometheus event hosted at George Washington School of Law with the Biotechnology Industry Organization created an opportunity for a panel of thought leaders to distill meaning from the case, the impact on personalized medicine, and possible solutions to the Court created problem.* Is the decision a game-changer? Judge Paul R. Michel, former Chief Judge of the Court of Appeals for the Federal Circuit handling patent cases, concluded that the Mayo v. Prometheus Read More >
